📰 Harvard Bioscience News
Harvard Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Harvard Bioscience. Real-time updates on events, politics, business and more.
June 7, 2024
Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) CEO James W. Green acquired 20,000 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was purchased at an average price of $3.07 per share, with a total value of $61,400.00. Following the acquisition, the chief executive officer now owns 3,101,091 shares […]
May 16, 2024
16.05.2024 - HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) - Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark ...
May 7, 2024
Strong gross margin performance and focus on efficiency to support ongoing investments in growthHOLLISTON, Mass., May 07, 2024 -- Harvard Bioscience, Inc. today announced financial results for...
April 9, 2024
HOLLISTON, Mass., April 09, 2024 -- Harvard Bioscience, Inc. today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The...
April 2, 2024
02.04.2024 - Established a Research Collaboration with the McGowan Institute for Regenerative Medicine at the University of Pittsburgh to Study the Repair and Regeneration of the Colon following ColectomyEstablished a Collaboration with Hugh Taylor, MD, chair of ...
March 25, 2024
It hasn't been the best quarter for Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders, since the share price has...
March 11, 2024
Market OverviewThe Hand Held Glucose Meter Market has witnessed significant growth in recent years, propelled by the increasing prevalence of diabetes and a rising awareness of the importance of regular blood glucose monitoring. This market encompasses a wide array of portable devices designed for convenient and qui...
March 9, 2024
Key Insights The projected fair value for Harvard Bioscience is US$6.70 based on 2 Stage Free Cash Flow to Equity...
February 27, 2024
27.02.2024 - HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) - Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a conference call to ...
February 27, 2024
HOLLISTON, Mass., Feb. 27, 2024 -- Harvard Bioscience, Inc. will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a...